
Polaryx Therapeutics Announces the Appointment of Dr. Eddy Zhu as Chief CMC Officer
PARAMUS, NJ, UNITED STATES, February 26, 2025 /EINPresswire.com/ -- Polaryx Therapeutics, a late-stage clinical biotech company developing drugs for lysosomal storage diseases, announces the appointment of Eddy Zhu, Ph.D., as Chief CMC Officer. …